Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Population Based, Prospective Study of the Care of Women with Epilepsy in Pregnancy
BMJ 321:674-675, Fairgrieve,S.D. et al, 2000
Clinical Specificities of Adult Male Patients with NMDA Receptor Antibodies Encephalitis
Neurol 82:556-563, Viaccoz, A.,et al, 2014
The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project
Clin Inf Dis 54:899-904, Gable, M.S.,et al, 2012
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009
Levetiracetam in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 67:1876-1879, Hung,S.,et al, 2006
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998